| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/02/2008 | CN101152331A Traditional Chinese medicine for treating Qi asthenia type hemorrhoid hemorrhage |
| 04/02/2008 | CN101152325A Traditional Chinese medicine for treating multiple hemorrhoid gall |
| 04/02/2008 | CN101152319A Traditional Chinese medicine for treating hemorrhoid gall |
| 04/02/2008 | CN101152291A Medicament for preventing and treating cardiovascular and cerebrovascular diseases, and method for preparing the same |
| 04/02/2008 | CN101152285A Pharmaceutical composition of snakegourd fruit and whitethorn leaf |
| 04/02/2008 | CN101152266A Traditional Chinese medicine preparations and use of the same |
| 04/02/2008 | CN101152248A Traditional Chinese medicine for treating post partum blood faint |
| 04/02/2008 | CN101152247A Pharmaceutical composition for cardiovascular and cerebrovascular diseases and method for preparing the same |
| 04/02/2008 | CN101152246A Pharmaceutical composition for cardiovascular and cerebrovascular diseases and method for preparing the same |
| 04/02/2008 | CN101152243A Traditional Chinese medicine for treating apoplexy and technique of preparing the same |
| 04/02/2008 | CN101152234A Application of cortex eucommiae lignans and its extract in against cardiovascular reconstruction |
| 04/02/2008 | CN101152233A Pharmaceutical composition of snakegourd fruit and folium ginkgo |
| 04/02/2008 | CN101152229A Notoginseng total saponin orally disintegrating tablets and method for preparing the same |
| 04/02/2008 | CN101152223A Use of poplar leaf phenols extract in treating cardiovascular disease and extracting method thereof |
| 04/02/2008 | CN101152221A Traditional Chinese medicine for treating cerebrovaseular disease |
| 04/02/2008 | CN101152205A Inosine injection and method of preparing the same |
| 04/02/2008 | CN101152194A Use of panaxoside Rg in against cerebral ischemia and relative diseases |
| 04/02/2008 | CN101152187A Eplerenone pharmaceutical composition |
| 04/02/2008 | CN101152182A Drug administration preparations of ligustrazine for nasal mucosa and method for preparing the same |
| 04/02/2008 | CN101152180A Pharmaceutical composition containing milrinone |
| 04/02/2008 | CN101152178A Sophoridine nano liposome medicament and preparation of the same |
| 04/02/2008 | CN101152171A Method of preparing mildronate injection |
| 04/02/2008 | CN101152166A Isoliquirtigenin gelling agent for treating hemorrhoids and method of preparing the same |
| 04/02/2008 | CN101152155A Hydrochloric acid Ivabradine solid pharmaceutical composition and method for preparing the same |
| 04/02/2008 | CN101152154A Hydrochloric acid dronedarone medicinal compositions for oral use and method for preparing the same |
| 04/02/2008 | CN101152151A Vascellum esoderma growth factor sustained-release corpuscle and method for preparing the same |
| 04/02/2008 | CN101152147A Ligustrazine compound emulsion and method for preparing the same |
| 04/02/2008 | CN101152146A Hydrochloric acid olprinone injection and method for preparing the same |
| 04/02/2008 | CN100378219C Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 04/02/2008 | CN100378119C Gen-seng saponin Rg2 preparation method, its pharmaceutical composition and uses in pharmacy |
| 04/02/2008 | CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives |
| 04/02/2008 | CN100378083C Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 04/02/2008 | CN100378075C Aniline derivative using as phosphodiesterase 4 inhibitor |
| 04/02/2008 | CN100377744C Compound medicine for predicting ACEI pressure reducing medicine effect |
| 04/02/2008 | CN100377742C Pharmaceutical formulation comprising low molecular weight thrombin inhibitor and its prodrug |
| 04/02/2008 | CN100377740C Therapeutic uses of beta-casein A2 and dietary supplement containing beta-casein A2 |
| 04/02/2008 | CN100377734C Extract of plant dendrobii caulis and preparing process and use thereof |
| 04/02/2008 | CN100377731C Chinese traditional medicine and its preparation method and use |
| 04/02/2008 | CN100377730C Kidney invigorating and heart nourishing Hongfu ointment |
| 04/02/2008 | CN100377715C Medicinal composition for curing cerebrovascular disease |
| 04/02/2008 | CN100377714C Application of steroidal sapogenins and their derivatives in medicine preparation |
| 04/02/2008 | CN100377711C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 04/01/2008 | US7351844 Adjust diffusion of oxygen; respiratory system disorders; cardiovascular disorders |
| 04/01/2008 | US7351840 Perindopril |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351821 Oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/01/2008 | US7351790 Peptide-based compounds |
| 04/01/2008 | US7351746 Anti-atherosclerosis composition containing carotenoids and method for inhibiting LDL oxidation |
| 04/01/2008 | US7351737 4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity |
| 04/01/2008 | US7351736 Therapeutic compositions (II) |
| 04/01/2008 | US7351732 Serotonin (5-hydroxytriptamine, 5-HT) 5-HT1A receptor subtype agonists; neuroprotective agents; cerebral damage due to traumatic or ischemic stroke; 2-[4-[(Chroman-2-yl)methylamine]butyl]-1,3-dioxoperhydropyrrolo[1,2-c]imidazol |
| 04/01/2008 | US7351730 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 04/01/2008 | US7351729 JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers |
| 04/01/2008 | US7351728 peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis |
| 04/01/2008 | US7351721 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
| 04/01/2008 | US7351711 Tricyclic indanyls as integrin inhibitors |
| 04/01/2008 | US7351707 Spiroazacyclic compounds as monoamine receptor modulators |
| 04/01/2008 | US7351705 Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 04/01/2008 | US7351702 Caspase inhibitors and uses thereof |
| 04/01/2008 | US7351697 Tumor-specific vector for gene therapy |
| 04/01/2008 | US7351695 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability |
| 04/01/2008 | US7351551 Adipocyte differentiation-associated gene and protein |
| 04/01/2008 | US7351436 Caffeic acid, chlorogenic acid and ferulic acid, and esters or salts, and one or more of central nervous system stimulating components, food fibers, extracts of plants, organic acids or sugar alcohols |
| 04/01/2008 | US7351410 Glycogen storage disease type II treatment comprising human acid glucosidase, mannitol and sucrose in aqueous solution |
| 04/01/2008 | CA2371896C Method of increasing the content of flavonoids and phenolic substances in plants |
| 04/01/2008 | CA2356240C Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications |
| 04/01/2008 | CA2356157C Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications |
| 04/01/2008 | CA2343299C Method for preventing or delaying catheter-based revascularization |
| 04/01/2008 | CA2298974C Thiazolobenzoheterocycles, preparation and medicines containing same |
| 04/01/2008 | CA2149408C Compositions for curing affected abnormal tissues, method for the preparation thereof, and usage thereof |
| 03/27/2008 | WO2008036807A2 Tea-derived compostiions and methods of using same for cardiovascular health |
| 03/27/2008 | WO2008036759A1 Spiro benzazepines as vasopressin antagonists |
| 03/27/2008 | WO2008036755A1 Spiro benzazepines used as vasopressin antagonists |
| 03/27/2008 | WO2008036247A1 Renin inhibitors |
| 03/27/2008 | WO2008036216A1 Piperidine derivatives as renin inhibitors |
| 03/27/2008 | WO2008036022A1 Tetrahydro-lh-pyrido[3,4-b] indole derivatives as cb1 receptor ligands |
| 03/27/2008 | WO2008036021A1 Tetrahydro-lh-pyrido [3,4 -b] indole derivatives as cbl receptor ligands |
| 03/27/2008 | WO2008035823A1 Cell death inhibitor |
| 03/27/2008 | WO2008035757A1 Jelly-like food containing ubiquinol |
| 03/27/2008 | WO2008035756A1 Anti-angiogenic composition comprising extract having anti-angiogenic activity and lecithin |
| 03/27/2008 | WO2008035359A2 Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives |
| 03/27/2008 | WO2008034815A1 Combination of nmda- receptor ligand and a compound with 5-ht6 receptor affinity |
| 03/27/2008 | WO2008034534A1 3-cyano-5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases |
| 03/27/2008 | WO2008019144A3 Threapeutic methods for treating vascular eye disorders with dll4 antagonists |
| 03/27/2008 | WO2008016884A3 Soluble epoxide hydrolase inhibitors |
| 03/27/2008 | WO2007147497A3 Use of a disintegrin-like and metalloproteinase with thrombospondin type 1 motif (adamts1) as a therapeutic or diagnostic target |
| 03/27/2008 | WO2007094513A3 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
| 03/27/2008 | WO2007084314A3 MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 03/27/2008 | WO2007053292A3 Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates |
| 03/27/2008 | WO2007045663A3 Combination of an ati receptor antagonist and a np inhibitor fro treating ia hypertension and heartfailure |
| 03/27/2008 | WO2006125621A8 Substituted piperidines as renin inhibitors |
| 03/27/2008 | WO2001022921A3 Prevention of atherosclerosis and undesired blood clotting by reducing von willebrand factor |
| 03/27/2008 | US20080077372 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 03/27/2008 | US20080076813 Benzene, Pyridine, and Pyridazine Derivatives |
| 03/27/2008 | US20080076800 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 03/27/2008 | US20080076786 Use of radical-scavenging compounds for treatment and prevention of no-dependent microcirculation disorders |
| 03/27/2008 | US20080076775 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 03/27/2008 | US20080076768 Pharmaceutical compounds |
| 03/27/2008 | US20080076766 Piperidine Derivatives As Renin Inhibitor |